Manoj Amrutkar

Oslo University Hospital

H指数:19

被引数:1,410

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Knowledge Discovery in Databases of Proteomics by Systems Modeling in Translational Research on Pancreatic Cancer

通过系统建模在胰腺癌转化研究中发现蛋白质组学数据库中的知识

Proteomes

IF3.6

2026-07-270

Proteomic characterization of primary pancreatic fibroblasts derived from neoadjuvant chemotherapy treated versus treatment-naïve PDAC

来自新辅助化疗治疗与未治疗胰腺导管腺癌的原代胰腺成纤维细胞的蛋白质组学表征

Journal of Proteomics

IF2.8

2026-04-210

OAAI

Proteomic Characterization of Primary Human Pancreatic Cancer Cell Lines Following Long-Term Exposure to Gemcitabine

人胰腺癌原代细胞系经长期吉西他滨处理后蛋白质组学表征

Proteomes

IF3.6

2026-03-030

OAAI

Reduced lipid metabolite abundance in human pancreatic cancer and matched serum samples following neoadjuvant FOLFIRINOX treatment

Metabolomics

IF3.3

2026-01-190

OAAI

Inhibition of GCKIII kinases STK25 and MST3 mitigates organ lipotoxicity and enhances metabolic resilience under nutritional stress

抑制GCKIII激酶STK25和MST3可减轻营养应激下的器官脂毒性并增强代谢韧性

BMC Medicine

IF8.3

2025-09-260

OAAI

Knowledge Discovery in Databases of Proteomics by Systems Modeling in Translational Research on Pancreatic Cancer

通过系统建模在胰腺癌转化研究中进行的蛋白质组学数据库知识发现

Proteomes 2025, Vol. 13, Page 20

IF3.6

2025-08-220

PRE

Proteomics profiling of research models for studying pancreatic ductal adenocarcinoma

胰腺导管腺癌研究模型中的蛋白质组学分析

SCIENTIFIC DATA

IF6.9

2025-02-140

Global metabolomic profiling of tumor tissue and paired serum samples to identify biomarkers for response to neoadjuvant FOLFIRINOX treatment of human pancreatic cancer

MOLECULAR ONCOLOGY

IF4.5

2024-11-150

Unravelling the complexities of resistance mechanism in pancreatic cancer: Insights from in vitro and ex-vivo model systems

SEMINARS IN CANCER BIOLOGY

IF15.7

2024-11-010

OAAI

Fatty acids abrogate the growth-suppressive effects induced by inhibition of cholesterol flux in pancreatic cancer cells

CANCER CELL INTERNATIONAL

IF6

2023-11-175

OAAI

Pancreatic stellate cell-induced gemcitabine resistance in pancreatic cancer is associated with LDHA- and MCT4-mediated enhanced glycolysis

CANCER CELL INTERNATIONAL

IF6

2023-01-1913

OAAI

Neoadjuvant chemotherapy is associated with an altered metabolic profile and increased cancer stemness in patients with pancreatic ductal adenocarcinoma

MOLECULAR ONCOLOGY

IF4.5

2022-12-057

Silencing of STE20-type kinase MST3 in mice with antisense oligonucleotide treatment ameliorates diet-induced nonalcoholic fatty liver disease

反义寡核苷酸沉默小鼠STE20-type激酶MST3改善饮食诱导的非酒精性脂肪性肝病

FASEB JOURNAL

IF4.2

2021-04-2318

Establishment and Characterization of Paired Primary Cultures of Human Pancreatic Cancer Cells and Stellate Cells Derived from the Same Tumor

CELLS

IF5.2

2020-01-165

OAAI

Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells

BMC CANCER

IF3.4

2019-06-1788

OAAI

Protein kinase MST3 modulates lipid homeostasis in hepatocytes and correlates with nonalcoholic steatohepatitis in humans

FASEB JOURNAL

IF4.2

2019-06-0723

OAAI

Commonly Used Pancreatic Stellate Cell Cultures Differ Phenotypically and in Their Interactions with Pancreatic Cancer Cells

CELLS

IF5.2

2019-01-0530

OAAI

Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY

IF7.4

2019-01-0142

OAAI

STK25 regulates oxidative capacity and metabolic efficiency in adipose tissue

JOURNAL OF ENDOCRINOLOGY

IF3.9

2018-09-0116

OAAI

STK25 Regulates Cardiovascular Disease Progression in a Mouse Model of Hypercholesterolemia

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

IF7.4

2018-08-0114

PREAI

Manoj Amrutkar

个人简介

教育背景

工作经历

荣誉奖项

研究方向